Statement Of Financial Position [Abstract]

Medistim - Filing #2546716

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
57 305 NOK
51 312 NOK
Deferred tax assets
5 142 NOK
3 591 NOK
Cash and cash equivalents
146 082 NOK
144 164 NOK
Assets
505 718 NOK
482 659 NOK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
4 585 NOK
4 585 NOK
Retained earnings
307 380 NOK
285 737 NOK
Share premium
41 852 NOK
41 852 NOK
Treasury shares
13,000 NOK
21,000 NOK
Other reserves
19 394 NOK
16 797 NOK
Equity
397 941 NOK
307 380 NOK
19 394 NOK
41 852 NOK
4 585 NOK
13,000 NOK
326 774 NOK
71 167 NOK
24 743 NOK
367 691 NOK
16 797 NOK
41 852 NOK
285 736 NOK
21,000 NOK
4 585 NOK
65 158 NOK
302 533 NOK
18 742 NOK
26,000 NOK
240 160 NOK
6 138 NOK
13 344 NOK
306 052 NOK
246 298 NOK
59 754 NOK
41 852 NOK
4 585 NOK
Liabilities [abstract]
Liabilities
107 777 NOK
114 967 NOK
Equity and liabilities
505 718 NOK
482 659 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.